Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

Clinical trial NCT07124819 · COMPLETED

Trial details

NCT number: NCT07124819
Sponsor: Avexima Diol LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee Venous Thromboembolism (VTE)Prevention

Start date: 2024-07-22
Primary completion: 2025-01-14
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.